We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

Home > News > Cultivation

Engineered Yeast Could Enable the Efficient Production of Pure Cannabinoids

Published: Oct 18, 2018   

Complete the form below and we will email you a PDF version of "Engineered Yeast Could Enable the Efficient Production of Pure Cannabinoids "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Analytical Cannabis?

Analytical Cannabis Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Engineered Yeast Could Enable the Efficient Production of Pure Cannabinoids

Intrexon, a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, has announced advances in the development of its microbial platform to produce cannabinoids for medical uses.  Through Intrexon's proprietary technologies, the company has engineered a yeast strain to produce low-cost, robust and consistent cannabinoid outputs via fermentation.  This process utilizing microbes has the potential to provide greater supply-chain security and avoids the resource-intensive isolation that often leads to quality and quantity variability in end products.


Further, this versatile strain was designed to enable the production of cannabinoids that only are produced today in minuscule amounts in cannabis plants as well as novel cannabinoids.  The company has scaled the process and achieved titers approaching commercially relevant targets with anticipated production of pure cannabinoids at COGS <$1,000/kg.


"As with some of our other similar projects, in thebaine, for example, microbial fermentation routes to produce cannabinoids provide advantages over traditional plant-based extraction," said Chris Savile, PhD, Executive Director, Commercial Operations.  "Through our capabilities and experience, we expect to optimize strains to produce specific cannabinoids that may be commercialized in the coming years


This article has been republished from materials provided by Intrexon. Note: material may have been edited for length and content. For further information, please contact the cited source.

 

Like what you just read? You can find similar content on the topic tag shown below.

Cultivation

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter

 
Advertisement